| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.430 | None | 1.000 | 1 | 2 | 2010 | 2018 | |||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.944 | 3 | 8 | 1983 | 2017 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2003 | 2017 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.180 | None | 1.000 | 1 | 1 | 2002 | 2018 | ||||||||
|
CLPTM1 like | 0.551 | 0.654 | 4.4E-05 |
|
disease | 0.150 | None | 1.000 | 1 | 2 | 2010 | 2018 | ||||||||
|
MDS1 and EVI1 complex locus | 0.513 | 0.731 | 1.00 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
gamma-aminobutyric acid type B receptor subunit 1 | 0.587 | 0.769 | 1.00 |
|
disease | 0.130 | None | 1.000 | 2 | 3 | 2009 | 2017 | ||||||||
|
integrin subunit alpha 9 | 0.621 | 0.692 | 8.2E-03 |
|
disease | 0.130 | None | 0.750 | 2 | 5 | 2009 | 2015 | ||||||||
|
TNF receptor superfamily member 19 | 0.700 | 0.423 | 3.3E-02 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.130 | None | 0.500 | 1 | 1 | 2010 | 2019 | |||||||||
|
cyclin dependent kinase 10 | 0.650 | 0.577 | 1.2E-16 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
downregulated RNA in cancer, inhibitor of cell invasion and migration | 0.736 | 0.423 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2019 | |||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2019 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 3 | 2010 | 2019 | ||||||||
|
microseminoprotein beta | 0.498 | 0.846 | 1.6E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
RAD51 paralog B | 0.556 | 0.769 | 2.1E-15 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2011 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2006 | 2010 | ||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2019 | |||||||||
|
prostate stem cell antigen | 0.555 | 0.615 | 0.17 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2015 | ||||||||
|
PDZ and LIM domain 5 | 0.525 | 0.808 | 1.7E-03 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2010 | 2019 | ||||||||
|
cholinergic receptor nicotinic alpha 3 subunit | 0.588 | 0.692 | 1.4E-07 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2010 | 2012 | ||||||||
|
methylthioadenosine phosphorylase | 0.514 | 0.731 | 7.6E-08 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2010 | 2015 | ||||||||
|
GRAM domain containing 1B | 0.736 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 | ||||||||
|
zinc ribbon domain containing 1 antisense, pseudogene | 0.691 | 0.538 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2010 | 2010 |